Showing 1-10 of about 1250 articles.
EffePharm (Shanghai) Co., Ltd
SHANGHAI, China, Dec. 12, 2019 (GLOBE NEWSWIRE) -- Effepharm announce that they acquired two bio-pharmaceutical companies recently, named Dendrimer Co. and Folvo Co., the acquisition has enhanced...
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Dec. 12, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
Toronto Innovation Acceleration Partners
Toronto, ON, Dec. 12, 2019 (GLOBE NEWSWIRE) -- The low survival rates of three of the four most lethal cancers in North America - pancreatic, colorectal and lung - are associated with KRAS...
Veloxis Pharmaceuticals A/S
Company Release no. 21/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 12 December 2019 Veloxis Pharmaceuticals: Publication of Offer...
Veloxis Pharmaceuticals A/S
Selskabsmeddelelse nr. 21/2019 Til: NASDAQ Copenhagen A/S København, Danmark 12. december 2019 Veloxis Pharmaceuticals: Offentliggørelse af...
BDA International
New York City, Dec. 11, 2019 (GLOBE NEWSWIRE) -- News yesterday from BDA International client Co-Diagnostics, Inc. (Nasdaq: CODX), a biotech with a patented platform for the development of molecular...
Onconova Therapeutics, Inc.
NEWTOWN, Pa., Dec. 10, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova” or the “Company”), a Phase 3-stage biopharmaceutical company discovering and developing novel...
Equillium
LA JOLLA, Calif., Dec. 09, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat...
Onconova Therapeutics, Inc.
Genomic Profiling at Study Entry in Patients with Higher Risk Myelodysplastic Syndrome (HR-MDS) Following Hypomethylating (HMA) Failure: Results From the INSPIRE Trial, including RAS and other...
Cybrexa Therapeutics
NEW HAVEN, Conn., Dec. 09, 2019 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a biotechnology company developing a new class of cancer therapeutics through its alphalex™ tumor targeting platform, today...
Showing 1-10 of about 1250 articles.
